• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动患者住院的驱动因素:更好地知情治疗心房颤动结局登记(ORBIT-AF)的结果。

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

机构信息

Duke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC.

Duke Clinical Research Institute, Durham, NC.

出版信息

Am Heart J. 2014 May;167(5):735-42.e2. doi: 10.1016/j.ahj.2014.02.003. Epub 2014 Feb 17.

DOI:10.1016/j.ahj.2014.02.003
PMID:24766985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4006943/
Abstract

BACKGROUND

Atrial fibrillation (AF) is the most common cardiac dysrhythmia and contributes significantly to health care expenditures. We sought to assess the frequency and predictors of hospitalization in patients with AF.

METHODS

The ORBIT-AF registry is a prospective, observational study of outpatients with AF enrolled from June 29, 2010, to August 9, 2011. The current analysis included 9,484 participants with 1-year follow-up. Multivariable, logistic regression was used to identify baseline characteristics that were associated with first cause-specific hospitalization.

RESULTS

Overall, 31% of patients with AF studied (n = 2,963) had 1 or more hospitalizations per year and 10% (n = 983) had 2 or more. The most common hospitalization cause was cardiovascular (20 per 100 patient-years vs 3.3 bleeding vs 17 noncardiovascular, nonbleeding). Compared with those not hospitalized, hospitalized patients were more likely to have concomitant heart failure (42% vs 28%, P < .0001), higher mean CHADS2 (1 point for congestive heart failure, hypertension, age ≥75, or diabetes; 2 points for prior stroke or transient ischemic attack) scores (2.5 vs 2.2, P < .0001), and more symptoms (baseline European Heart Rhythm Association class severe symptoms 18% vs 13%, P < .0001). In multivariable analysis, heart failure (adjusted hazard ratio [HR] 1.57 for New York Heart Association III/IV vs none, P < .0001), heart rate at baseline (adjusted HR 1.11 per 10-beats/min increase >66, P < .0001), and AF symptom class (adjusted HR 1.37 for European Heart Rhythm Association severe vs none, P < .0001) were the major predictors of incident hospitalization.

CONCLUSIONS

Hospitalization is common in outpatients with AF and is independently predicted by heart failure and AF symptoms. Improved symptom control, rate control, and comorbid condition management should be evaluated as strategies to reduce health care use in these patients.

摘要

背景

心房颤动(AF)是最常见的心律失常,对医疗保健支出有重大影响。我们旨在评估 AF 患者住院的频率和预测因素。

方法

ORBIT-AF 登记是一项针对 2010 年 6 月 29 日至 2011 年 8 月 9 日期间招募的门诊 AF 患者的前瞻性观察性研究。本分析包括 9484 名患者,随访 1 年。多变量逻辑回归用于确定与首次特定病因住院相关的基线特征。

结果

总体而言,研究的 AF 患者中有 31%(n=2963)每年有 1 次或多次住院,10%(n=983)有 2 次或多次住院。最常见的住院原因是心血管(每 100 患者年 20 例与 3.3 例出血,17 例非心血管非出血)。与未住院患者相比,住院患者更有可能同时患有心力衰竭(42%与 28%,P<0.0001),更高的平均 CHADS2 评分(充血性心力衰竭、高血压、年龄≥75 岁或糖尿病各 1 分;既往卒中或短暂性脑缺血发作各 2 分)(2.5 与 2.2,P<0.0001),以及更多的症状(基线欧洲心脏节律协会严重症状 18%与 13%,P<0.0001)。多变量分析显示,心力衰竭(纽约心脏协会 III/IV 级与无心力衰竭相比,调整后的危险比[HR]为 1.57,P<0.0001)、基线时的心率(每增加 10 次/分,调整后的 HR 为 1.11,P<0.0001)和 AF 症状分级(欧洲心脏节律协会严重症状与无症状相比,调整后的 HR 为 1.37,P<0.0001)是事件性住院的主要预测因素。

结论

AF 门诊患者的住院治疗很常见,独立预测因素为心力衰竭和 AF 症状。应评估改善症状控制、心率控制和合并症管理作为降低这些患者医疗保健使用的策略。

相似文献

1
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).心房颤动患者住院的驱动因素:更好地知情治疗心房颤动结局登记(ORBIT-AF)的结果。
Am Heart J. 2014 May;167(5):735-42.e2. doi: 10.1016/j.ahj.2014.02.003. Epub 2014 Feb 17.
2
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.伴有和不伴有糖尿病的心房颤动患者的护理模式和结局:ORBIT-AF 登记研究。
J Am Coll Cardiol. 2017 Sep 12;70(11):1325-1335. doi: 10.1016/j.jacc.2017.07.755.
3
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).心房颤动对心力衰竭患者死亡率、卒中风险及生活质量评分的影响(源自心房颤动更优治疗结局注册研究[ORBIT-AF])
Am J Cardiol. 2017 Jun 1;119(11):1763-1769. doi: 10.1016/j.amjcard.2017.02.050. Epub 2017 Mar 16.
4
Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study.心房颤动患者住院的发生率和预测因素:来自中国心房颤动注册研究的结果。
BMC Cardiovasc Disord. 2021 Mar 19;21(1):146. doi: 10.1186/s12872-021-01951-5.
5
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).阻塞性睡眠呼吸暂停及持续气道正压通气治疗对心房颤动患者预后的影响——心房颤动更优知情治疗结果登记研究(ORBIT-AF)的结果
Am Heart J. 2015 May;169(5):647-654.e2. doi: 10.1016/j.ahj.2014.12.024. Epub 2015 Feb 7.
6
Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).心房颤动症状、生活质量与患者预后之间的关联:心房颤动更明智治疗结局登记研究(ORBIT-AF)的结果
Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):393-402. doi: 10.1161/CIRCOUTCOMES.114.001303. Epub 2015 Jun 9.
7
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.在有房颤病史的患者中,新发心力衰竭的预测因素及其预后意义。
JACC Heart Fail. 2017 Jan;5(1):44-52. doi: 10.1016/j.jchf.2016.09.016.
8
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.在心房颤动患者中同时使用阿司匹林治疗和口服抗凝治疗的情况及相关风险:来自 Outcomes Registry for Better Informed Treatment of Atrial Fibrillation(ORBIT-AF)登记研究的见解。
Circulation. 2013 Aug 13;128(7):721-8. doi: 10.1161/CIRCULATIONAHA.113.002927. Epub 2013 Jul 16.
9
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分(CHADS2与CHA2DS2-VASc)对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
10
CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.CHADS2 和 CHA2DS2-VASc 风险因素预测心房颤动/心房扑动患者首次心血管住院事件。
Am J Cardiol. 2012 May 15;109(10):1526-33. doi: 10.1016/j.amjcard.2012.01.371. Epub 2012 Feb 22.

引用本文的文献

1
Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank.初级和二级医疗数据在心房颤动确诊中的作用:对英国生物银行中危险因素关联、患者管理及死亡率的影响
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euae291.
2
Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold.心房颤动的多学科治疗方法:堪比黄金。
J Clin Med. 2024 Aug 7;13(16):4621. doi: 10.3390/jcm13164621.
3
Incidence of All-Cause, Cardiovascular, and Atrial Fibrillation-Related Hospitalizations: Focus on Antiarrhythmic Drugs.全因、心血管及心房颤动相关住院的发生率:聚焦抗心律失常药物
JACC Adv. 2024 Jul 12;3(8):101117. doi: 10.1016/j.jacadv.2024.101117. eCollection 2024 Aug.
4
Diagnostic Accuracy of Left Atrial/Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.心房颤动患者左心房/左心耳血栓的诊断准确性:一项系统评价和网状Meta分析
Rev Cardiovasc Med. 2023 Nov 27;24(11):334. doi: 10.31083/j.rcm2411334. eCollection 2023 Nov.
5
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients.心房颤动患者的静脉血栓栓塞:对4,170,027例患者的系统评价和荟萃分析
JACC Adv. 2023 Aug 16;2(7):100555. doi: 10.1016/j.jacadv.2023.100555. eCollection 2023 Sep.
6
Assessing the impact of atrial fibrillation self-care interventions: A systematic review.评估心房颤动自我护理干预措施的影响:一项系统评价。
Am Heart J Plus. 2024 May 13;43:100404. doi: 10.1016/j.ahjo.2024.100404. eCollection 2024 Jul.
7
A pilot study of the quality of care of atrial fibrillation in Irish general practice.爱尔兰全科医疗中房颤护理质量的初步研究。
Fam Pract. 2024 Oct 8;41(5):817-824. doi: 10.1093/fampra/cmae001.
8
Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells.凝血因子Xa对PAR1、PAR2和PAR4的表达无影响,对HL-1细胞无促炎作用。
Cells. 2023 Dec 15;12(24):2849. doi: 10.3390/cells12242849.
9
Trends in Atrial Fibrillation Management-Results from a National Multi-Center Urgent Care Network Registry.心房颤动管理趋势——来自全国多中心紧急护理网络登记处的结果
J Clin Med. 2023 Oct 24;12(21):6704. doi: 10.3390/jcm12216704.
10
New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry.CLARIFY 注册研究中新发心房颤动与慢性冠脉综合征。
Eur Heart J. 2024 Feb 1;45(5):366-375. doi: 10.1093/eurheartj/ehad556.

本文引用的文献

1
Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation.房颤患者门诊中基于证据的心脏预防治疗的应用。
Am J Med. 2013 Jul;126(7):625-32.e1. doi: 10.1016/j.amjmed.2013.01.037.
2
Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation.两种不同节律控制策略在老年有症状持续性心房颤动患者中的长期疗效和安全性。
J Cardiovasc Electrophysiol. 2013 Jul;24(7):731-8. doi: 10.1111/jce.12126. Epub 2013 Apr 1.
3
Readmission among hospitalized patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动住院患者的再入院情况。
Am J Health Syst Pharm. 2013 Mar 1;70(5):414-22. doi: 10.2146/ajhp120461.
4
Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study.与心房颤动相关的心血管和非心血管医院入院:一项丹麦全国性、回顾性队列研究。
BMJ Open. 2013 Jan 24;3(1):e001800. doi: 10.1136/bmjopen-2012-001800.
5
The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia.与心力衰竭和心肌梗死相比,心房颤动的负担日益加重:一项对澳大利亚所有住院病例的15年研究。
Arch Intern Med. 2012 May 14;172(9):739-41. doi: 10.1001/archinternmed.2012.878.
6
Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.≥65 岁伴有房颤/房扑患者的住院率及相关影响因素。
Am J Cardiol. 2012 Feb 15;109(4):543-9. doi: 10.1016/j.amjcard.2011.10.009. Epub 2011 Nov 24.
7
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.房颤治疗知情选择结局注册研究:ORBIT-AF 的研究背景和设计。
Am Heart J. 2011 Oct;162(4):606-612.e1. doi: 10.1016/j.ahj.2011.07.001.
8
Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.心房颤动患者的抗凝控制与不良事件预测:一项系统评价
Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):84-91. doi: 10.1161/CIRCOUTCOMES.108.796185. Epub 2008 Nov 5.
9
Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications.
J Interv Card Electrophysiol. 2009 Jun;25(1):31-5. doi: 10.1007/s10840-008-9346-7. Epub 2009 Jan 16.
10
Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control.心房颤动患者的华法林治疗:观察与不同国际标准化比值(INR)控制水平相关的结果。
Thromb Res. 2009 May;124(1):37-41. doi: 10.1016/j.thromres.2008.09.016. Epub 2008 Dec 4.